Trial intelligence / Profile preview

RMGI Varnish for Preventing White Spot Lesions in Orthodontics

NCT03711097Phase 4Withdrawn

Sponsor
University of Nebraska
Start
Apr 2019
Primary completion
Apr 2019
Modality
Small Molecules
01

Overview

A Phase 4 trial of Vanish XT Extended Contact Varnish in White spot lesion (WSL), sponsored by University of Nebraska. Planned start Apr 2019; status: withdrawn.

02

Drugs

Vanish XT Extended Contact Varnish
03

Conditions

White spot lesion (WSL)

Beyond the preview

Go deeper on NCT03711097.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03711097.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call